Fast-tracked skin cancer drug pembrolizumab gets approval

Last Updated on Wednesday, 03 February 2016 14:08
Published on Thursday, 08 October 2015 10:32
Hits: 7886

BBC report that a new drug for advanced skin cancer should be made available on the NHS in England, experts recommend. 

The National Institute for Health and Care Excellence says pembrolizumab is cost-effective to use in patients who have already tried not benefited from another drug called ipilimumab.  The treatment is considered a "next generation" drug in cancer care, stimulating the body's immune system to fight the disease. 

For further information visit the BBC website.

This is continuing evidence of the amount of research being undertaken in this area of medicine.